Dr Rubesh Patel, PHARM D in Irvington, AL - Pharmacist

Dr Rubesh Patel, PHARM D is a Pharmacist based in Irvington, Alabama. Dr Rubesh Patel is licensed to practice in Alabama (license number 15915) and his current practice location is 12855 Padgett Switch Rd, Irvington, Alabama. He can be reached at his office (for appointments etc.) via phone at (251) 824-7979.

NPI number for Dr Rubesh Patel is 1861089617 and his current mailing address is 12855 Padgett Switch Rd, Irvington, Alabama. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1861089617.

Contact Information

	Dr Rubesh Patel, PHARM D
	12855 Padgett Switch Rd, Irvington, AL 36544-4015
	(251) 824-7979
	(251) 824-7989

Healthcare Provider's Profile

Full Name	Dr Rubesh Patel
Gender	Male
Speciality	Pharmacist
Location	12855 Padgett Switch Rd, Irvington, Alabama
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1861089617
Provider Enumeration Date: 12/28/2020
Last Update Date: 12/28/2020

Medical Identifiers

Medical identifiers for Dr Rubesh Patel such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1861089617	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	15915 (Alabama)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Rubesh Patel is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Rubesh Patel, PHARM D 12855 Padgett Switch Rd, Irvington, AL 36544-4015 Ph: (251) 824-7979	Dr Rubesh Patel, PHARM D 12855 Padgett Switch Rd, Irvington, AL 36544-4015 Ph: (251) 824-7979

News Archive

New study of tribe shows influence of Western diet and lifestyle on blood pressure

A South American tribe living in near-total isolation with no Western dietary influences showed no increase in average blood pressure from age one to age 60, according to a study led by researchers at Johns Hopkins Bloomberg School of Public Health.

Scientists develop new chip to increase forensic DNA testing speed

A newly developed test could make checking DNA from people arrested for crimes with DNA samples from crime scenes stored in forensic databases almost as easy as matching fingerprints. With the test, police could check on whether a person's DNA matches that found at past crime scenes while suspects are still being processed and before a decision on whether to release them on bail. A report on the fast forensic test appears in the ACS' Analytical Chemistry, a semi-monthly journal.

Biomarin commences BMN 701 Phase 1/2 trial for treatment of Pompe disease

BioMarin Pharmaceutical Inc. announced today that it has initiated a Phase 1/2 trial for BMN 701, a novel fusion protein of insulin-like growth factor 2 and acid alpha glucosidase in development for the treatment of Pompe disease.

AVEO submits tivozanib NDA with FDA for treatment of advanced renal cell carcinoma

AVEO Oncology and Astellas Pharma Inc. today announced that AVEO has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for tivozanib in patients with advanced renal cell carcinoma (RCC).

Dr Rubesh Patel, PHARM D - Pharmacist in Irvington, AL